Slørdal L - Search Results

1

Interactions with the protein binding of 7-hydroxy-methotrexate in human serum in vitro.

Slørdal L, Sager G, Jaeger R, Aarbakke J. Slørdal L, et al. Biochem Pharmacol. 1988 Feb 15;37(4):607-11. doi: 10.1016/0006-2952(88)90132-3. Biochem Pharmacol. 1988. PMID: 3342097

2

Pharmacokinetic interactions with methotrexate: is 7-hydroxy-methotrexate the culprit?

Slørdal L, Sager G, Aarbakke J. Slørdal L, et al. Lancet. 1988 Mar 12;1(8585):591-2. doi: 10.1016/s0140-6736(88)91387-6. Lancet. 1988. PMID: 2894526 No abstract available.

3

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapy.

Slørdal L, Kolmannskog S, Prytz PS, Moe PJ, Aarbakke J. Slørdal L, et al. Pediatr Hematol Oncol. 1986;3(2):127-34. doi: 10.3109/08880018609031208. Pediatr Hematol Oncol. 1986. PMID: 3153222

4

Effect of anticancer drugs on drug metabolism.

Slørdal L, Aarbakke J. Slørdal L, et al. Pharmacol Ther. 1987;35(1-2):217-26. doi: 10.1016/0163-7258(87)90107-0. Pharmacol Ther. 1987. PMID: 3321100 Review. No abstract available.

5

Pharmacokinetics of 7-hydroxy-methotrexate and methotrexate in the rat.

Slørdal L, Jaeger R, Kjaeve J, Aarbakke J. Slørdal L, et al. Pharmacol Toxicol. 1988 Aug;63(2):81-4. doi: 10.1111/j.1600-0773.1988.tb00915.x. Pharmacol Toxicol. 1988. PMID: 3186623

6

High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.

Slørdal L, Kolmannskog S, Moe PJ, Prytz PS, Aarbakke J. Slørdal L, et al. Pediatr Hematol Oncol. 1987;4(1):33-42. doi: 10.3109/08880018709141247. Pediatr Hematol Oncol. 1987. PMID: 3152911

7

Effects of 3-deazaadenosine, an inducer of HL-60 cell differentiation, on human blood cells in vitro.

Prytz S, Loennechen T, Johansson A, Larsen LB, Slørdal L, Aarbakke J. Prytz S, et al. Among authors: slordal l. Pediatr Hematol Oncol. 1989;6(2):173-9. doi: 10.3109/08880018909034283. Pediatr Hematol Oncol. 1989. PMID: 2702071

8

Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.

Bremnes RM, Slørdal L, Wist E, Aarbakke J. Bremnes RM, et al. Among authors: slordal l. Cancer Res. 1989 Nov 15;49(22):6359-64. Cancer Res. 1989. PMID: 2804982

9

Lactoferrin and C-reactive protein in response to cytostatic drugs with emphasis on methotrexate.

Gutteberg TJ, Slørdal L, Kolmannskog S. Gutteberg TJ, et al. Among authors: slordal l. Pediatr Hematol Oncol. 1987;4(4):315-22. doi: 10.3109/08880018709141284. Pediatr Hematol Oncol. 1987. PMID: 3152937

10

Distribution of 7-hydroxymethotrexate in human blood.

Slørdal L, Sager G, Huseby NE, Aarbakke J. Slørdal L, et al. J Pharm Pharmacol. 1988 Jan;40(1):50-2. doi: 10.1111/j.2042-7158.1988.tb05149.x. J Pharm Pharmacol. 1988. PMID: 2896774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results